A. James Culverwell
Independent DirectorMr. A. James Culverwell, BSc., is Director of TC Biopharm Limited. Mr. Culverwell is Non-Executive Independent Director of TC Biopharm (Holdings) Plc from February 2022. Mr. Culverwell was a Principal of Sudbrook Associates LLP, an FSA regulated healthcare corporate finance firm part owned by New Smith Capital Partners in the City of London. Mr. Culverwell has experience in the pharmaceutical industry through a successful career in pharmaceutical company analysis, investment banking and latterly in healthcare private equity. He joined Hoare Govett in 1982. Mr. Culverwell served as Director of European Healthcare Research at ABN AMRO. He joined Merrill Lynch in 1995. He served as Research Analyst at BofA Merrill Lynch, Research Division and Equity Analyst at RBS Research. From 1994 to 2005, he served as First Vice President of Merrill Lynch Equity Research, as Head of European Healthcare Research and as its Global Coordinator Pharmaceutical Research. In 1994, Mr. Culverwell served on the London Stock Exchange task force to determine revised listing criteria for emerging healthcare companies. He also served with European Pharmaceutical corporate activity, including the flotation of Wellcome and the mergers of SmithKline with Beecham, Astra with Zeneca and Aventis with Sanofi. He was also involved in the successful IPOs of a number of healthcare companies, including ML Laboratories, Scotia, Biocompatibles, Serono and Alcon. He serves as Director of Sudbrook Associates LLP. He served as an Independent Director at Innocoll Holdings plc (formerly known as Innocoll AG) from March 16, 2016 to July 24, 2017. He served as has been a Member of Supervisory Board at Innocoll Holdings plc (formerly known as Innocoll AG) since August 2013 until March 16, 2016. He served as Non-Executive Director of Atlantic Healthcare Limited. He graduated from the University of Aberdeen (MSc).
Positions
- Company NameQuoin Pharmaceuticals, Ltd.Stock CodeQNRXPositionIndependent Director
- Company NameTC Biopharm (Holdings) PlcStock CodeTCBWFPositionNon-Executive Independent Director
